Траниласт (Tranilast)
Международное непатентованное наименование
Траниласт (Tranilast)
Торговое наименование
Rizaben
Производитель, страна
Kissei Pharmaceuticals, Japan
Механизм действия
It is used in Japan, South Korea, and China to treat asthma, keloid scars, and hypertrophic scars, and as an ophthalmic solution for allergic pink eye. It should not be taken by women who are or might become pregnant, and it is secreted in breast milk.
Клинические исследования
1.
Название протокола
Clinical study of novel NLRP Inflammasome inhibitor (Tranilast) in the treatment of novel coronavirus pneumonia (COVID-19)
Дата начала и окончания КИ
February 15, 2020 - July 30, 2020
Название организации, проводящей КИ
The First Affiliated Hospital of University of science and technology of China (Anhui Provincial Hospital)
Страны
China
Фаза
IV
Кол-во пациентов
60